Podcasts about Monty

November 7th, 2025 Follow us on Facebook, Instagram and X Listen to past episodes on The Ticket’s Website And follow The Ticket Top 10 on Apple, Spotify or Amazon MusicSee omnystudio.com/listener for privacy information.

November 7th, 2025 Follow us on Facebook, Instagram and X Listen to past episodes on The Ticket’s Website And follow The Ticket Top 10 on Apple, Spotify or Amazon MusicSee omnystudio.com/listener for privacy information.

November 6th, 2025 We gather up the brain trust of the Sweet Spot (Sean Bass & David Mino) & the Hardline (Corby Davidson, Bob Sturm & Dave Lane) led by Monty to give us birthdays, shoutouts, 'on this day in history' and any other nuggets to show you Why Today Doesn't Suck. Follow us on Facebook, Instagram and X Listen to past episodes on The Ticket’s Website And follow The Ticket Top 10 on Apple, Spotify or Amazon MusicSee omnystudio.com/listener for privacy information.

November 7th, 2025 We gather up the brain trust of the Sweet Spot (Sean Bass & David Mino) & the Hardline (Corby Davidson, Bob Sturm & Dave Lane) led by Monty to give us birthdays, shoutouts, 'on this day in history' and any other nuggets to show you Why Today Doesn't Suck. Follow us on Facebook, Instagram and X Listen to past episodes on The Ticket’s Website And follow The Ticket Top 10 on Apple, Spotify or Amazon MusicSee omnystudio.com/listener for privacy information.

(00:00) - Doug's in the Hamptons for his son's wedding. Charlie Marlow will come in today around 9 and we love that Chuck Marlow. Martin tells some great Charlie Marlow origin stories. Producer Joe. Martin's memory can get a little bit wonky. Doug and Martin MC'd an event last night. This event turned into a little bit of a Rams settlement debate. (22:00) - Blues got the win last night. Strong outing from Hofer. Jordan Kyrou a healthy scratch last night. Monty's comments about the healthy scratch. Harrison's Brother Master claims he changed his bet following the Kyrou scratch. Joey and Kerbs broke it down last night. (44:00) - Brand New Key. Brent Key at Georgia Tech with an outstanding clip of his allegiance to GT amid all the coaching rumors. The fellas break it down and compare it across College Football. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

(00:00) - Pat Benatar. Binnington and the stolen puck situation. Ovi's response. The TNT crew was entertained by Binner's antics. Texters are simply not happy. What will the response be tonight following the Sabres game? Thursday Night Football. (12:00) - Kerbs and Joey were critical of the goaltending efforts as of late. Martin goes through some of the numbers, and they are not good. Monty's comments were very telling last night. Would you bet on Buffalo tonight against the note? People sending in pictures of their wife. Tim's hotel situation in Columbia. We love the Colonel. College Sports coverage. (36:00) - Cat Daddy. Jackson dancing. Josh Pate's take on Mizzou vs. Texas A&M this weekend. Could Mizzou truly pull the upset this weekend. Jackson wants it bad. Looking at the Penn State schedule next year compared to Missouri See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Monty Pal and Dr. Pauline Funchain discuss the latest efforts to diagnose, prevent, and treat the series of immune-related adverse events that have emerged in the era of immunotherapy. TRANSCRIPT Dr. Monty Pal: Hello, and welcome to the ASCO Daily News Podcast. I am Monty Pal, a medical oncologist, professor and vice chair of medical oncology at the City of Hope Comprehensive Cancer Center in Los Angeles, California. Now, it is probably no surprise to this audience that immunotherapy has transformed the treatment landscape for multiple cancer types. It remains a pillar of modern oncology. Having said that, I think we have all been baffled by certain toxicities that we run into in the clinic. Today, I am delighted to be joined by Dr Pauline Funchain to discuss some of the checkpoint inhibitor toxicities that people struggle with most. And we will also touch on some side effects of immunotherapy beyond checkpoint inhibitors: CAR-T cells, bispecifics, so on and so forth. Dr Funchain is a dear friend, and she is an associate professor and associate director of cancer research training and education at the Stanford Cancer Institute. She is co-director of the Immunotherapy Toxicity Program and the Skin Cancer Genomics Program at Stanford, where she also serves as associate program director of hematology and oncology fellowship. Dr. Funchain is also the co-founder of ASPIRE, and we are going to talk about that a little bit today, the Alliance for the Support and Prevention of Immune-Related Events. FYI for listeners, if you are interested in our disclosures, they are available at the transcript of this episode. Pauline, thanks so much for joining us today. Dr. Pauline Funchain: Monty, thank you for this invitation. It is always great to talk. Dr. Monty Pal: So, for the audience, Pauline and I know each other from my days as a fellow at City of Hope. She was a resident at Harbor UCLA and a stellar resident at that. It has just been amazing to sort of see your career grow and blossom and to witness all the cool things that you are doing. ASPIRE, in particular, sort of caught my eye. So again, for listeners, this is the Alliance for the Support and Prevention of Immune-Related Events. Can you tell us a little bit briefly about the genesis of that, how that came about? Dr. Pauline Funchain: So, there was a bunch of us who were really struggling, I mean, all of us have struggled with these immune-related adverse events, these irAEs. You know, they are new disease states, and even though they look like autoimmune diseases, they tend to need a whole lot more steroid than autoimmune diseases do and they do not totally present in the same way. And in fact, you know, Triple-M, or Triple-M overlap syndrome, is a completely new irAE, a new immune state that we have never had before the advent of checkpoint inhibitor. And so a Triple-M, for those of you who are not as familiar, that is the constellation of myocarditis, myositis, and myasthenia gravis, something that never occurs as a natural autoimmune disease. So we were starting to realize that there were some major differences with these irAEs and autoimmune diseases. We could not treat them the right way. We really needed to learn more about them. And a bunch of us who had interest in this said, "Look, we really need to be all in one space to talk about what we are doing," because all of our treatments were our own little homegrown brews, and we needed to really get together and understand how to treat these things, how to diagnose them, and then learn more about them. So, Dr. Alexa Meara from Ohio State, Dr. Kerry Reynolds from Mass Gen, we put together this research consortium, brought together all of our irAE friends, got our best subspecialists together in a research consortium, which is now only about a year and a half old. And we made this research consortium, the Alliance for Support of Prevention of Immune-Related Events, and we reached out to ASCO, and ASCO was so kind to grant us a [Alliance for Support and Prevention of Immune-Related adverse Events (ASPIRE)] Community of Practice. So we met for the first time as a Community of Practice at the ASCO Annual Meeting just this past June and really got an ASCO community together to really think about how to again, diagnose, prevent, treat irAEs. Dr Monty Pal: This is interesting to me. The ASCO Community of Practice phenomenon is something that I was not super familiar with. Can you explain to our listenership what is the ASCO Community of Practice model? If you have particular interests, how do you sort of get one started? Dr Pauline Funchain: Yeah, so ASCO has an entire page on their Community of Practice. There are multiple Community of Practice groups or COPs. There are ones for Supportive Oncology and Survivorship. There is Women in Oncology. There is a group for International Medical Graduates. And there is about, I think 10 or 12 now that have a physical presence at ASCO but also a virtual presence on the ASCO Community of Practice site. So, if you were interested in any one of these, and you can see them on the ASCO Communities of Practice sites, you would ask to become a member. Once granted membership, then there is a whole webpage of postings and conversations that people can have. You can get email digests of conversations that happen on the website, and then you can anchor it with in-person participation at the Annual Meeting. Dr Monty Pal: That is awesome, and I can think of so many different foci within oncology that really sort of deserve a Community of Practice. This definitely being one of them. You know, it strikes me as being so interesting. I mean, the checkpoint inhibitors have been around for a while now. I think when you and I were in training, gosh, back then, these were just a little bit of a pipe dream, right? But having said that, I would probably say that more than half of my kidney cancer practice is either on checkpoint inhibitors, and the vast majority have been on one at some point in their past, right? With that in mind, you know, we have all treated a lot of patients with these drugs. Why is it that we still struggle to manage the toxicities? And just to take that one step further, what are some of the toxicities that, perhaps through ASPIRE or through your experience, people struggle with the most? Dr Pauline Funchain: So, I think we are still struggling with these because again, they are new disease states, right? This is what we all experienced with COVID, a brand-new virus and a brand-new syndrome. We now have 20-plus of these as irAEs. And what we have realized about them is the immune activation that happens with these is so much more than what we have seen with autoimmune diseases. So for instance, if you have a Crohn's or ulcerative colitis, you will top out at 40 to 60 milligrams of prednisone if a Crohn's flare or ulcerative colitis flare happens. But for our severe IR colitises, you know, it is at least 1 mg per kg, often goes up to 2 mg per kg. We, in some cases, have done 1 gram pulses if we are worried that somebody is going to perforate. So that was sort of like the first 5 years of treating irAE, and then now in the sort of second 5 years of treating irAE, we have realized that that is a lot of immunosuppression, and we might be able to get away with less with the newer biologics that are on board. So, we are struggling to try to get the data for some of these irAEs that we knew, we have known for a while, but to try to get newer treatments that may immunosuppress less so that you may still be able to retain that tumor response. And in fact, some of the preclinical studies suggest that some of these biologics may actually synergize with the immunotherapy and actually make the immunotherapy more effective from a tumor perspective and calm down the irAE as sort of the bystander effect. So we are still trying to optimize those. Getting up trials in the space has been very difficult. That is one of the reasons for the genesis of ASPIRE because we realized we needed to band together to have a bigger voice in that realm. Then there are other things that are brand new. So we talked about Triple-M. So Triple-M, again, with Triple-M or any myocarditis or myasthenia, I mean, there is about a 50% chance of death from irAE based on the literature. I think we are getting better at recognizing this, and so at Stanford we have some data to say that if you serially follow troponin, that maybe your outcomes are better. You can potentially lower the percentage of cases that are fatal because you can catch them early. I mean, this is all preliminary data, but again, these are all things that are evolving, and we do not all have the right answer. I mean, even the serial troponin thing, I think, is pretty controversial. And in fact, at one of our quarterly Zoom meetings that we are doing in ASPIRE in December is going to sort of flush out that controversy about serial troponin measuring and what is the best thing to use? Would you use something like abatacept or would you use ruxolitinib? Which one is better? I think there is a lot of controversy still about these things. Dr Monty Pal: You have really piqued my curiosity here because you think about the cons of treating irAEs, right? And I worry exactly about what you had mentioned, right, which is, "Gosh, what is going on with this tumor in terms of immunosuppression?" But you think about some of the newer agents, you mentioned ruxolitinib, I have heard of dasatinib, for instance, in this setting. Frankly speaking, a lot of these, as you point out, are really thought of as being also anticancer drugs. So you have really got me thinking about the potential synergy between perhaps suppressing an irAE and augmenting antitumor activity, which I think is very interesting. Am I on the right track with that? Dr Pauline Funchain: I think so, but you will find that a lot of people will not even go there because they are worried about how much immunosuppression you are going to cause. I am at heart a geneticist, but I think an immunologist will happily tell you that the immune system is very complex. There are multiple pathways, and these drugs do not all target the same immune pathways. So if we understand a little bit more about the pathways we are targeting and pick apart the pathways that are really, really tumor relevant and the other pathways that are not tumor relevant, you may be able to piece together a better marriage of tumor response and irAE control. Dr Monty Pal: Kind of on this topic, and again, leaning on your background in genetics, where are we in terms of predicting these irAEs? I mean, you would think the holy grail would be picking out a snip or something of this for it, right, that could potentially identify that patient who is going to get Triple-M or, you know, at the very least a significant high-grade irAE event. Are we anywhere closer to that in 2025? Dr Pauline Funchain: There have been data published. There have been some big GWAS studies. All of the effect sizes are pretty small. So there are some prediction algorithms, but none of them are clinically useful. And I think when you look at the odds ratios, they will increase risk by maybe 20%. I think one of the things that we found in a very small series and supported anecdotally is something as easy as family history of autoimmune disease is probably more predictive at this point than any of those types of markers. I think we will get there, but we are not anywhere near where we would like to be. Things like TMB also, actually, there is some good data about higher TMB, higher risk of irAE too. Dr Monty Pal: Interesting. I see all this data coming through, IL-8 polymorphisms, etc. And I just wondered if any of that was ready for prime time. But I mean, this is a good message for the practicing clinician. Sounds like we are not quite there yet. And I could probably keep you on for another entire podcast to talk about this topic, but let us see if we can at least skim the surface. I never thought I would see the day when BiTEs and CAR-Ts were entering into my kidney cancer practice, but in fact, it is really become central to a lot of our clinical trials in RCC these days. I would be lying if I did not say that I was not struggling with the toxicities and so forth associated with these drugs. Can you give us a quick primer, maybe just good resources that people can go to for managing toxicity with BiTEs and with CAR and with some of these novel therapeutic modalities that we are using in the oncology clinics? Dr Pauline Funchain: I know there is a recently published toxicity manual for BiTEs in hematologic malignancies, I think it was in Blood. CAR-T is covered in many irAE guidelines. So ASCO guidelines actually has a CAR-T [cell therapy guideline], and I would be remiss not to point out that actually ASCO has a, I am a little biased, but a wonderful guideline on irAE that is actually being updated as we speak. We are hoping for publication next year. I find the format of that, there are many guidelines out there, actually. There is ASCO, SITC, ESMO has a guideline for irAE, but I find the formatting of the ASCO guideline to be much easier to flip through during clinic, just because of the visual format of the tables. But that is going to be updated next year. And with CAR-T, there is now multiple publications also in terms of guidelines. But what I will say about bispecifics and CAR-T, so they have very similar toxicities in terms of the cytokine release and also with the ICANS, so the neurotoxicity. But what we have been finding that is really interesting with BiTEs and CAR-T, and actually even with TIL, cytokine release is very similar to some of the IL-2 toxicities but not identical that we see with TIL treatment. But now we are starting to see overlap. So patients who have been treated with immunotherapy and then go on to get a bispecific or then go on to get TIL, so I have seen some colitises that have occurred after the fact. Some of the newer CAR-Ts without checkpoint have been causing some really interesting, probably not in a good way, but interesting biologically, colitises that are really refractory. So we are starting to see some overlap, and again, I think this field is just evolving constantly. Dr Monty Pal: Yeah, no, I almost think I need to go back to that fellowship that you and I did together 20 years ago and, you know, and see if I could repeat some coursework on CAR-T management.  You know, Pauline, I could probably keep you on the horn for hours, but this has just been terrific. Thank you so much for sharing all of your insights with us today on the ASCO Daily News Podcast. Dr Pauline Funchain: Thank you for the invitation. It was wonderful to talk about this, and it was wonderful to catch up a little bit, Monty. Dr Monty Pal: Same here, same here. And thanks to our listeners too. If you value the insights you heard today on the ASCO Daily News Podcast, please rate, review, and subscribe wherever you get your podcasts. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions.  Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Find out more about today's speakers:      Dr. Monty Pal    @montypal   Dr. Pauline Funchain @FunchainMD Follow ASCO on social media:       @ASCO on Twitter      ASCO on Bluesky     ASCO on Facebook       ASCO on LinkedIn     Disclosures: Dr. Monty Pal:     Speakers' Bureau: MJH Life Sciences, IntrisiQ, Peerview    Research Funding (Inst.): Exelixis, Merck, Osel, Genentech, Crispr Therapeutics, Adicet Bio, ArsenalBio, Xencor, Miyarsian Pharmaceutical    Travel, Accommodations, Expenses: Crispr Therapeutics, Ipsen, Exelixis    Dr. Pauline Funchain: Consulting or Advisory Role: Merck, Replimune, Sanofi/Regeneron, Immunocore, Tempus Research Funding (Inst.): Pfizer, Bristol-Myers Squibb, IDEAYA Biosciences, Linnaeus Therapeutics Travel, Accommodations, Expenses: Merck

November 4th, 2025 We gather up the brain trust of the Sweet Spot (Sean Bass & David Mino) & the Hardline (Corby Davidson, Bob Sturm & Dave Lane) led by Monty to give us birthdays, shoutouts, 'on this day in history' and any other nuggets to show you Why Today Doesn't Suck. Follow us on Facebook, Instagram and X Listen to past episodes on The Ticket’s Website And follow The Ticket Top 10 on Apple, Spotify or Amazon MusicSee omnystudio.com/listener for privacy information.

November 5th, 2025 We gather up the brain trust of the Sweet Spot (Sean Bass & David Mino) & the Hardline (Corby Davidson, Bob Sturm & Dave Lane) led by Monty to give us birthdays, shoutouts, 'on this day in history' and any other nuggets to show you Why Today Doesn't Suck. Follow us on Facebook, Instagram and X Listen to past episodes on The Ticket’s Website And follow The Ticket Top 10 on Apple, Spotify or Amazon MusicSee omnystudio.com/listener for privacy information.

HUMBLED & THANKFUL, A 12 STEP JOURNEY. In this episode of the Came to Believe Recovery Podcast, Monty and Tom discuss the themes of gratitude and humility in the context of recovery. They explore listener questions about finding sponsors, dealing with family during the holidays, and the importance of gratitude lists. The conversation emphasizes the significance of living in service to others and how struggles can lead to personal growth and deeper appreciation for life. The hosts also touch on the interconnectedness of gratitude and humility, and how these qualities can enhance the recovery journey. #recovery #alcoholic #twelvesteps #wedorecover #addiction 

This week, Dr Monty tells us about a treatment she’s about to try in the hopes of easing her anxiety, depression and migraines, and Dr Mel thinks she’s uncovered a potential nervous system disruptor lurking in most of our homes. There’s also Mel’s fact, a great take on anxiety from Monty’s BFF Chris Hemsworth, and the stupid products no one needs in their life. Enjoy! Fancy supporting us on Patreon? Find out more here. Follow us and get in touch on Instagram here. Follow us on Facebook here.See omnystudio.com/listener for privacy information.

There is one show where insiders share their secrets in this city. One person that they trust and respect. Opinion, reaction and the highest level of informed sports talk in Montreal. Melnick in the Afternoon, with Mitch Melnick and Jon Still.

Monty reveals the biggest gardening lessons he's learned during his career, including how to use colour and light in the garden throughout the year. Discover his love of visiting gardens for their stories and life, how important it is to connect with the natural world and the joy of creating something that connects people and plants. Recorded at Gardeners' World Live in June. Learn more about your ad choices. Visit podcastchoices.com/adchoices

To support this ministry and help us continue to reach people all around our region, click here: http://bethel.ag/give/Stay Connected Website: www.bethel.ag Bethel Church Facebook: www.facebook.com/bethelchurch605/ Bethel Church Instagram: www.instagram.com/bethelchurch605/

There is one show where insiders share their secrets in this city. One person that they trust and respect. Opinion, reaction and the highest level of informed sports talk in Montreal. Melnick in the Afternoon, with Mitch Melnick.

November 3rd, 2025 We gather up the brain trust of the Sweet Spot (Sean Bass & David Mino) & the Hardline (Corby Davidson, Bob Sturm & Dave Lane) led by Monty to give us birthdays, shoutouts, 'on this day in history' and any other nuggets to show you Why Today Doesn't Suck. Follow us on Facebook, Instagram and X Listen to past episodes on The Ticket’s Website And follow The Ticket Top 10 on Apple, Spotify or Amazon MusicSee omnystudio.com/listener for privacy information.

Sermon Notes Date: 11/02/2025 Preacher: Monty Simao, pastor Series: Wisdom and Worship: Walking Through Psalms and Proverbs Key Text: Psalm 11 Description: The wicked rise, justice fails, and chaos reigns. What do you do when the foundations of life collapse? David — the very shepherd-warrior who would one day be king — tells us in […]

On this week's episode we discuss how Sam Montembeault's season has slowly gotten away from him, the Habs passing all their tests in October and complete our Top 10 Montreal Canadiens goal scorers since 1994.

Rivals Break down what to expect this NBA Season! Where will the Lakers, Celtics and your favorite team place? Who will be the 10 Playoff teams in each conference?  Who will play for the title and ultimately cut down the nets?  Plus, we tell you who we believe will be first team All NBA and win the MVP!  Give you a hint, it rhymes with Puka!  Letʻs do this!

A leather jacket, an iconic eagle logo, and a three-chord blur that changed everything—tour manager Monte A. Melnick joins us to reveal how the Ramones became an institution without ever chasing the charts. From booking chaos and van miles to Sire Records deals and night-after-night precision, Monty shares the systems and scrapes that kept the band loud, fast, and on time.We go inside the job nobody sees: shows and hotels, wrangling crews, negotiating with agents, and surviving mismatched arena bills where batteries and ice picks rained from the crowd. Monte explains why the Ramones doubled down on headlining their own rooms, how CBGB's gave them a lab to refine short, no-solo songs, and why minimalism was a deliberate design, not a limitation. He walks through Joey's rise from drums to the mic, Dee Dee's volcanic creativity and volatility, Tommy's drum architecture to Marky's transition, and Johnny's iron will that protected the brand.If you've ever wondered how a band with modest sales became a global touchstone, this conversation connects the dots: discipline over myth, craft over chaos, and a road team that made it all possible. Listen, share with a fellow Ramones fan, and leave a review to tell us your favorite track—and why it still hits.Learn Something New orRemember Something OldLike and follow our Facebook and Instagram pages and spread the word if you enjoy the podcast. Contact us at musicinmyshoes@gmail.com with your own musical memories.Send us a one-way message. We can't answer you back directly, but it could be part of a future Music In My Shoes Mailbag!!!

It's the final episode of Season 8 of Where's That Bar Cart! Darryl's in the UK, Monty's in his favourite shirt, and Nick dons a new golf vest *courtesy of our friends at Red Rooster. We ask AI to summarize this season, and Nick walks the boys through a wild and somewhat accurate description. As the saying goes: Easy to Come, Hard to Say.Thanks to Comedy Records and to each and every one of you who listens, watches, and supports our podcast. Please subscribe to our YouTube channel @ComedyRecords. Swing well out there everyone. Follow us at:- @wheresthatbarcart- linkt.ree/wheresthatbarcart- @dpurcomic- @montymofoscott- @nickdurie- @comedyrecordsMusic by Devin BatesonThank you to Comedy Records

October 31st, 2025 We gather up the brain trust of the Sweet Spot (Sean Bass & David Mino) & the Hardline (Corby Davidson, Bob Sturm & Dave Lane) led by Monty to give us birthdays, shoutouts, 'on this day in history' and any other nuggets to show you Why Today Doesn't Suck. Follow us on Facebook, Instagram and X Listen to past episodes on The Ticket’s Website And follow The Ticket Top 10 on Apple, Spotify or Amazon MusicSee omnystudio.com/listener for privacy information.

Join Debbie Loucks on a special episode of Horsemanship Radio as she kicks off a brand new series! Each month, we'll delve into a chapter from Monty Roberts' insightful book, Horse Sense for People. Discover how Monty's revolutionary, non-violent communication techniques with horses offer invaluable lessons for human relationships, business, and personal growth. This series aims to share Monty's timeless wisdom and inspiring stories with everyone, free of charge. Tune in on the 1st and 15th of every month for new episodes of Horsemanship Radio! Listen in... Horsemanship Radio 290:Show Host: Debbie LoucksTitle Sponsor: HandsOn Gloves, All-In-One Shedding/Bathing/Grooming GlovesPhotos used with permissionPurchase your own copy of Horse Sense for PeopleLearn more about Good Horsemanship at Monty Roberts EQUUS Online University Monty's CalendarPlease follow Monty Roberts on FacebookFollow Monty Roberts on Twitter or on InstagramSee more at: MontyRoberts.comHear all the shows on the Horse Radio NetworkSupport the showMentioned in this episode:Hands On Gloves & Monty Roberts University

Join Debbie Loucks on a special episode of Horsemanship Radio as she kicks off a brand new series! Each month, we'll delve into a chapter from Monty Roberts' insightful book, Horse Sense for People. Discover how Monty's revolutionary, non-violent communication techniques with horses offer invaluable lessons for human relationships, business, and personal growth. This series aims to share Monty's timeless wisdom and inspiring stories with everyone, free of charge. Tune in on the 1st and 15th of every month for new episodes of Horsemanship Radio! Listen in... Horsemanship Radio 290:Show Host: Debbie LoucksTitle Sponsor: HandsOn Gloves, All-In-One Shedding/Bathing/Grooming GlovesPhotos used with permissionPurchase your own copy of Horse Sense for PeopleLearn more about Good Horsemanship at Monty Roberts EQUUS Online University Monty's CalendarPlease follow Monty Roberts on FacebookFollow Monty Roberts on Twitter or on InstagramSee more at: MontyRoberts.comHear all the shows on the Horse Radio NetworkSupport the showMentioned in this episode:Hands On Gloves & Monty Roberts University

October 30th, 2025 Follow us on Facebook, Instagram and X Listen to past episodes on The Ticket’s Website And follow The Ticket Top 10 on Apple, Spotify or Amazon MusicSee omnystudio.com/listener for privacy information.

October 30th, 2025 We gather up the brain trust of the Sweet Spot (Sean Bass & David Mino) & the Hardline (Corby Davidson, Bob Sturm & Dave Lane) led by Monty to give us birthdays, shoutouts, 'on this day in history' and any other nuggets to show you Why Today Doesn't Suck. Follow us on Facebook, Instagram and X Listen to past episodes on The Ticket’s Website And follow The Ticket Top 10 on Apple, Spotify or Amazon MusicSee omnystudio.com/listener for privacy information.

October 29th, 2025 We gather up the brain trust of the Sweet Spot (Sean Bass & David Mino) & the Hardline (Corby Davidson, Bob Sturm & Dave Lane) led by Monty to give us birthdays, shoutouts, 'on this day in history' and any other nuggets to show you Why Today Doesn't Suck. Follow us on Facebook, Instagram and X Listen to past episodes on The Ticket’s Website And follow The Ticket Top 10 on Apple, Spotify or Amazon MusicSee omnystudio.com/listener for privacy information.

October 28th, 2025 We gather up the brain trust of the Sweet Spot (Sean Bass & David Mino) & the Hardline (Corby Davidson, Bob Sturm & Dave Lane) led by Monty to give us birthdays, shoutouts, 'on this day in history' and any other nuggets to show you Why Today Doesn't Suck. Follow us on Facebook, Instagram and X Listen to past episodes on The Ticket’s Website And follow The Ticket Top 10 on Apple, Spotify or Amazon MusicSee omnystudio.com/listener for privacy information.

October 27th, 2025 We gather up the brain trust of the Sweet Spot (Sean Bass & David Mino) & the Hardline (Corby Davidson, Bob Sturm & Dave Lane) led by Monty to give us birthdays, shoutouts, 'on this day in history' and any other nuggets to show you Why Today Doesn't Suck. Follow us on Facebook, Instagram and X Listen to past episodes on The Ticket’s Website And follow The Ticket Top 10 on Apple, Spotify or Amazon MusicSee omnystudio.com/listener for privacy information.

October 24th, 2025 We gather up the brain trust of the Sweet Spot (Sean Bass & David Mino) & the Hardline (Corby Davidson, Bob Sturm & Dave Lane) led by Monty to give us birthdays, shoutouts, 'on this day in history' and any other nuggets to show you Why Today Doesn't Suck. Follow us on Facebook, Instagram and X Listen to past episodes on The Ticket’s Website And follow The Ticket Top 10 on Apple, Spotify or Amazon MusicSee omnystudio.com/listener for privacy information.

Monty sits down with Stanford star, Jimmy Nati!

This week, Mel kicks us off with a cool fact for travellers, Monty gets called out for her shocking investigative skills, and we reminisce about a much-loved clothing staple for teenage girls in the 90s. We ponder the murkiness of whether it's ok to put toxic stuff into your bod when someone has donated one of their organs to you, how quickly you should reply to texts, and disagree on what degree of lateness warrants a courtesy text. Enjoy! Fancy supporting us on Patreon? Find out more here. Follow us and get in touch on Instagram here. Follow us on Facebook here. See omnystudio.com/listener for privacy information.

Matt Haugen - Monty's Plant Food Crop Update

The final battle is coming, but first Monty and Von Arnim will try for spoiling attacks. Neither get far, thus it comes down to Operation Vulcan. Learn more about your ad choices. Visit megaphone.fm/adchoices

Who Knew It with Matt Stewart is a comedy game show podcast hosted by Australian comedian Matt Stewart. Episode 163 features comedians Monty Frankin, Frankie McNair and Alasdair Tremblay-Birchall!Check out Matt's new stand up special: https://youtu.be/ZgukEPerWZc?si=SW8PttGAB-ly_GF8And his last stand up special: https://youtu.be/cWStRpI-BhESupport the show via http://patreon.com/dogoonpod and you can submit questions for the show!See the podcast/Matt live: https://www.mattstewartcomedy.com/Check out Matt's podcast network: https://dogoonpod.com/Theme song by Evan Munro-Smith, Logo by Murray Summerville and edited by Connor Schmidt! Hosted on Acast. See acast.com/privacy for more information.

Monty sits down with NC State slugger, Chris McHugh!

Sermon Notes Date: 10/26/2025 Preacher: Josh Peglow, pastor Series: Colossians Key Text: Colossians 3:1-4 Description: What if the most practical way to live with what's in front… begins by looking up? Today on Scandia Bible Church Podcast, Pastor Josh Peglow returns to our study in the book of Colossians — where Paul moves from theology […]

Dodgers and Blue Jays split the first 2 games in Toronto and Monty breaks down the Jays game 1 explosion followed by Yoshi Yamamotoʻs second straight complete game victory in game 2! Plus, NFL Week 9 where the Jets and Dolphins win as the Steelers lose! Plus, NBA Gambling saga!

To support this ministry and help us continue to reach people all around our region, click here: http://bethel.ag/give/Stay Connected Website: www.bethel.ag Bethel Church Facebook: www.facebook.com/bethelchurch605/ Bethel Church Instagram: www.instagram.com/bethelchurch605/

Monty Franklin is back for another sterling edition of the pod. Watch the full video on YOUTUBE HERE Join the PATREON HERE - Just $7 (AUD) for bonus eps and content - get tons of behind the scenes hacks and pranks and help keep this podcast going! Go watch Capper's special Hold Me Closer Tiny Cancer HERE Follow CAPPER and MIKE and PHONE HACKS on Instagram Subscribe where you're listening and leave a review to get the word out there.See omnystudio.com/listener for privacy information.

The Foolishness of Alcohol - Monty Joiner by Somerville St Church of Christ

October 23rd, 2025 We gather up the brain trust of the Sweet Spot (Sean Bass & David Mino) & the Hardline (Corby Davidson, Bob Sturm & Dave Lane) led by Monty to give us birthdays, shoutouts, 'on this day in history' and any other nuggets to show you Why Today Doesn't Suck. Follow us on Facebook, Instagram and X Listen to past episodes on The Ticket’s Website And follow The Ticket Top 10 on Apple, Spotify or Amazon MusicSee omnystudio.com/listener for privacy information.

October 22nd, 2025 We gather up the brain trust of the Sweet Spot (Sean Bass & David Mino) & the Hardline (Corby Davidson, Bob Sturm & Dave Lane) led by Monty to give us birthdays, shoutouts, 'on this day in history' and any other nuggets to show you Why Today Doesn't Suck. Follow us on Facebook, Instagram and X Listen to past episodes on The Ticket’s Website And follow The Ticket Top 10 on Apple, Spotify or Amazon MusicSee omnystudio.com/listener for privacy information.

Monty's interview with Harrison Didawick!

Monty sits down with Miami star Daniel Cuvet!

October 20th, 2025 We gather up the brain trust of the Sweet Spot (Sean Bass & David Mino) & the Hardline (Corby Davidson, Bob Sturm & Dave Lane) led by Monty to give us birthdays, shoutouts, 'on this day in history' and any other nuggets to show you Why Today Doesn't Suck. Follow us on Facebook, Instagram and X Listen to past episodes on The Ticket’s Website And follow The Ticket Top 10 on Apple, Spotify or Amazon MusicSee omnystudio.com/listener for privacy information.

October 21st, 2025 We gather up the brain trust of the Sweet Spot (Sean Bass & David Mino) & the Hardline (Corby Davidson, Bob Sturm & Dave Lane) led by Monty to give us birthdays, shoutouts, 'on this day in history' and any other nuggets to show you Why Today Doesn't Suck. Follow us on Facebook, Instagram and X Listen to past episodes on The Ticket’s Website And follow The Ticket Top 10 on Apple, Spotify or Amazon MusicSee omnystudio.com/listener for privacy information.

Sur cet épisode de Le Sick Podcast, Eric Hoziel, Mathias Brunet, Denis Gauthier et Jack Han se joignent à Tony Marinaro! Learn more about your ad choices. Visit megaphone.fm/adchoices

October 17th, 2025 We gather up the brain trust of the Sweet Spot (Sean Bass & David Mino) & the Hardline (Corby Davidson, Bob Sturm & Dave Lane) led by Monty to give us birthdays, shoutouts, 'on this day in history' and any other nuggets to show you Why Today Doesn't Suck. Follow us on Facebook, Instagram and X Listen to past episodes on The Ticket’s Website And follow The Ticket Top 10 on Apple, Spotify or Amazon MusicSee omnystudio.com/listener for privacy information.

October 16th, 2025 We gather up the brain trust of the Sweet Spot (Sean Bass & David Mino) & the Hardline (Corby Davidson, Bob Sturm & Dave Lane) led by Monty to give us birthdays, shoutouts, 'on this day in history' and any other nuggets to show you Why Today Doesn't Suck. Follow us on Facebook, Instagram and X Listen to past episodes on The Ticket’s Website And follow The Ticket Top 10 on Apple, Spotify or Amazon MusicSee omnystudio.com/listener for privacy information.